Prevalence of vancomycin-resistant enterococcus in prenatal screening cultures

Area of Science:

• Obstetrics and Gynecology
• Infectious Diseases
• Microbiology

Background:

• Perinatal treatment guidelines for Streptococcus agalactiae (Group B Strep) recommend vancomycin for patients with severe penicillin allergies or resistant strains.
• Concerns exist regarding postpartum infections from vancomycin-resistant enterococci (VRE) and the potential for spreading vancomycin resistance.
• Understanding VRE prevalence in pregnant populations is critical for risk assessment and management.

Purpose of the Study:

• To determine the prevalence of vancomycin-resistant enterococci (VRE) in prenatal screening cultures.
• To assess the potential risk of VRE-related postpartum infections.
• To inform strategies for managing antibiotic resistance in perinatal care.

Main Methods:

• Analysis of prenatal screening cultures for the presence of VRE.
• Microbiological identification and susceptibility testing of VRE isolates.
• Epidemiological assessment of VRE colonization rates in a pregnant cohort.

Main Results:

• The study quantified the prevalence of VRE colonization in the studied pregnant population.
• Specific rates of VRE identified in prenatal screening cultures were reported.
• Data on the susceptibility patterns of identified VRE strains were collected.

Conclusions:

• The findings provide essential data on VRE prevalence in pregnant women undergoing prenatal screening.
• This information is vital for evaluating the risk associated with vancomycin use in this population.
• Results can guide clinical practice and public health strategies to mitigate the spread of antibiotic resistance.